Daxor Corp

DXR

Company Profile

  • Business description

    Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. The company operates as a single business segment centered on the development, commercialization, and support of its proprietary blood volume analysis technology used by healthcare providers.

  • Contact

    107 Meco Lane
    Oak RidgeTN37830
    USA

    T: +1 212 330-8500

    E: [email protected]

    https://www.daxor.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2026

    Employees

    750

Stocks News & Analysis

stocks

Reassuring organic growth for undervalued ASX share

Efficiency gains are starting to make their mark.
stocks

Big IPOs are enticing but are they good investments?

Historically, buzzy debuts have been painful for buyers.
stocks

This defensive ASX listed REIT offers a 5% yield

Solid outlook underpinned by rent uplifts and development pipeline.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,697.50139.10-1.57%
CAC 408,080.7466.09-0.81%
DAX 4025,463.81272.43-1.06%
Dow JONES (US)49,097.061,101.11-2.19%
FTSE 10010,452.6898.49-0.93%
HKSE22,435.24406.38-1.78%
NASDAQ23,879.20550.69-2.25%
Nikkei 22556,967.052,477.16-4.17%
NZX 50 Index14,102.30144.95-1.02%
S&P 5007,175.83147.80-2.02%
S&P/ASX 2008,597.60132.80-1.52%
SSE Composite Index3,521.4056.22-1.57%

Market Movers